Influenza Vaccine Market to Grow at CAGR of around 9% during 2012-2017
Rising demand for influenza vaccine from the elderly population backed by entry of new players in the market, will boost the segment’s growth, says RNCOS.
Noida, India -- (SBWire) -- 08/22/2013 --As per the new research report by RNCOS, “Global Vaccine Market Forecast to 2017”, world is anticipated to witness the production of around 1.3 Billion doses of seasonal influenza vaccines by the end of 2013. Entry of new manufacturers and clearance of new vaccines through trial phases are going to impact the market in a positive manner. Increased awareness of the need for vaccination against influenza, broader recommendations for vaccination and aging populations are fueling the growth in the world market for flu vaccines, which is expected to reach to grow at a CAGR of around 9% during 2012-2017.
In the report, the vaccine market has been studied on three distinct levels: Regional, Therapeutic Category and Company. For regional analysis, key vaccine markets that together constitute around 90% of the global market, have been profiled. Further, the market has been broken down into 16 distinct therapeutic categories and their current and future outlook to 2017 has been analyzed. Through this, our analysts have conducted a thorough opportunity assessment in various therapeutic categories and regions to clearly highlight avenues which offer maximum opportunities for growth.
The study further delves into the business dynamics of the major players in industry. To provide a thorough understanding of the company’s business model, company’s current and historical financials have been analyzed. Moreover, our team has also analyzed each company’s strengths and weaknesses along with its vaccine portfolio and pipeline that will help the reader to better position its company vis-à-vis competition. This will help the reader to gain a deeper insight into each key market player.
The report provides a thorough research and rational analysis of the current status and expected position of the global vaccines market. It facilitates the future forecasts on the total vaccines market, therapeutic categories and regional markets. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify key opportunities and design suitable business strategies.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM491.htm
Some of our Related Reports are:
- US Cancer Vaccine Market Analysis (http://www.rncos.com/Report/IM457.htm)
- Global Vaccine Market Forecast to 2013 (http://www.rncos.com/Report/IM357.htm)
- Global Influenza Vaccine Market Analysis (http://www.rncos.com/Report/IM356.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
Media Relations Contact
Vartika Sehgal
Sr. Research Specialist
RNCOS
91-120-4224-700
http://www.rncos.com
View this press release online at: http://rwire.com/309968